QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boelens, P. G. Articles by van Leeuwen, P. A. M. Search for Related Content PubMed PubMed Citation Articles by Boelens, P. G. Articles by van Leeuwen, P. A. M.

---

Supplement

Glutamine Alimentation in Catabolic State¹

Department of Surgery, University Hospital Vrije Universiteit, Amsterdam, The Netherlands

³To whom correspondence should be addressed. E-mail: pam.vleeuwen{at}azvu.nl

Glutamine should be reclassified as a conditionally essential amino acid in the catabolic state because the body’s glutamine expenditures exceed synthesis and low glutamine levels in plasma are associated with poor clinical outcome. After severe stress, several amino acids are mobilized from muscle tissue to supply energy and substrate to the host. Glutamine is one of the most important amino acids that provide this function. Glutamine acts as the preferred respiratory fuel for lymphocytes, hepatocytes and intestinal mucosal cells and is metabolized in the gut to citrulline, ammonium and other amino acids. Low concentrations of glutamine in plasma reflect reduced stores in muscle and this reduced availability of glutamine in the catabolic state seems to correlate with increased morbidity and mortality. Adding glutamine to the nutrition of clinical patients, enterally or parenterally, may reduce morbidity. Several excellent clinical trials have been performed to prove efficacy and feasibility of the use of glutamine supplementation in parenteral and enteral nutrition. The increased intake of glutamine has resulted in lower septic morbidity in certain critically ill patient populations. This review will focus on the efficacy and the importance of glutamine supplementation in diverse catabolic states.

KEY WORDS: • glutamine • catabolic state • trauma • surgery • critically ill

This article has been cited by other articles:

				D. Schachter L-Glutamine in vitro regulates rat aortic glutamate content and modulates nitric oxide formation and contractility responses Am J Physiol Cell Physiol, July 1, 2007; 293(1): C142 - C151. [Abstract] [Full Text] [PDF]

				Y.-F. Huang, Y. Wang, and M. Watford Glutamine Directly Downregulates Glutamine Synthetase Protein Levels in Mouse C2C12 Skeletal Muscle Myotubes J. Nutr., June 1, 2007; 137(6): 1357 - 1362. [Abstract] [Full Text] [PDF]

				P. G. Boelens, G. C. Melis, P. A. van Leeuwen, G. A. ten Have, and N. E. Deutz Route of administration (enteral or parenteral) affects the contribution of L-glutamine to de novo L-arginine synthesis in mice: a stable-isotope study Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E683 - E690. [Abstract] [Full Text] [PDF]

				H. A. Choudry, M. Pan, A. M. Karinch, and W. W. Souba Branched-Chain Amino Acid-Enriched Nutritional Support in Surgical and Cancer Patients J. Nutr., January 1, 2006; 136(1): 314S - 318S. [Abstract] [Full Text] [PDF]

				P. G. Boelens, P. A. M. van Leeuwen, C. H. C. Dejong, and N. E. P. Deutz Intestinal renal metabolism of L-citrulline and L-arginine following enteral or parenteral infusion of L-alanyl-L-[2,15N]glutamine or L-[2,15N]glutamine in mice Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G679 - G685. [Abstract] [Full Text] [PDF]

				R. Minet-Quinard, C. Moinard, F. Villie, M. P. Vasson, and L. Cynober Metabolic pathways implicated in the kinetic impairment of muscle glutamine homeostasis in adult and old glucocorticoid-treated rats Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E671 - E676. [Abstract] [Full Text] [PDF]

				S. Claeyssens, C. Gangneux, C. Brasse-Lagnel, P. Ruminy, T. Aki, A. Lavoinne, and J.-P. Salier Amino acid control of the human glyceraldehyde 3-phosphate dehydrogenase gene transcription in hepatocyte Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G840 - G849. [Abstract] [Full Text] [PDF]

				E. Nakamura and S. J. Hagen Role of glutamine and arginase in protection against ammonia-induced cell death in gastric epithelial cells Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1264 - G1275. [Abstract] [Full Text] [PDF]